A representative distribution of expression across samples in cancer tissue and corresponding NAT (Supplementary Fig. 7a) and GTEx normal tissue (Supplementary Fig. 7b) is shown to illustrate this threshold for frequent expression. This evidence concerns the gene BRD2 and cancer.